Close Menu

NEW YORK (GenomeWeb) – Singlera Genomics said today that it has raised $60 million in Series A+ financing led by Green Pine Capital Partners and Prosperico Ventures.

La Jolla, California- and Shanghai-based Singlera said that it will use the funds to help expand the development and commercialization of its non-invasive genetic tests for early-stage cancer detection and to fund clinical validation studies. The firm said that it will also use the funds to further expand its research facilities and its TitanSeq and Monod platforms into new product lines.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.